J. Joseph Kim
President and CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Inovio Pharmaceuticals, Inc. (INO) | Former President and Chief Executive Officer | $523,714 | $10,472,297 |
| 2021 | Inovio Pharmaceuticals, Inc. (INO) | Former President and Chief Executive Officer | $844,056 | $6,223,600 |
| 2020 | Inovio Pharmaceuticals, Inc. (INO) | President and Chief Executive Officer | $694,645 | $4,707,676 |
| 2019 | Inovio Pharmaceuticals, Inc. (INO) | President and Chief Executive Officer | $837,735 | $2,588,534 |
| 2018 | Inovio Pharmaceuticals, Inc. (INO) | President and Chief Executive Officer | $726,798 | $3,081,043 |
| 2017 | Inovio Pharmaceuticals, Inc. (INO) | President, Chief Executive Officer and Director | $780,007 | $4,389,268 |
Executive changes
Earnings-call appearances
-
Inovio Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2021-12-31
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-09
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-09
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-10
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2021-03-01
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q3 FY2020 Earnings Call2020-11-09
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q2 FY2020 Earnings Call2020-08-10
Inovio Pharmaceuticals, Inc. (INO)
-
Inovio Pharmaceuticals, Inc. Q1 FY2020 Earnings Call2020-05-11
Inovio Pharmaceuticals, Inc. (INO)